The area of Life Sciences, as all sectors of so-called high-technology, is characterized by a world-wide market. In fact, the biotech companies are quickly brought to cross borders to identify the right partners to enable them to ensure their development and growth.
Lyonbiopole therefore, as part of its support to international, offers its encouragement to SMBs in the development of strategic partnerships and that, going fom scientific technology partnership to co-development or co-marketing partnership.
The goal is simple, encouraging business’ growth, whether scientific point of view through the emergence of new collaborative R&D projects, as the technological point of view through the establishment of partnerships or joint development yet the business perspective by signing a contract with a client.
Lyonbiopole does not stop there and establishes its own agreements with partner clusters. Once again, the objectives are multiple:
> The exchange of good practices and information between clusters and the implementation of joint
> Visibility and recognition in the international division
> The use of partner clusters as a gateway for our SMEs on foreign markets.
An international development focused on the main global markets
Europe
In just a few years, Lyonbiopole has managed to integrate into European networks and has developed many partnerships:
> Alps Bio Cluster project (Interreg project – Alpine Space)
> Italy - Piedmont: partnership agreements with BiPCa / bioPmed
> Israel: collaboration with Matimop
> Belgium: Collaboration with BioWin – Wallonia’s cluster
> Thematic network on medical systemic approaches in partnership with Stockholm, Munich, Amsterdam, Leicester, Luxembourg
More information
Outside Europe/International
Lyonbiopôle does not stop at Europe's borders and collaborate with many partners around the world:
> United States: Boston (MA), San Diego / SF (CA), Baltimore (MD)
> Japan, Kansai: A collaboration agreement with KBCP under the CFL
> Canada (Quebec): A collaboration agreement with the CQVB in the CFL
> China, Shanghai: Technological cooperation and higher education projects, a LIFE hustle and bustle
More information
Lyonbiopole’s Toolbox for corporate support in the International
Beyond and in addition to partnerships established throughout the world, Lyonbiopole develops tools and actions to support companies in their international steps and ensuring a profile of skills and expertise present in the region and French territory.
The International Technology Partnership Program (PPTI)
The PPTI is a program to support the international development of SME cluster members by encouraging them in setting up technological cooperation with European and international partners. In the past 3 years, Lyonbiopole has been supporting 45 companies in their international development.
More information
This program is made with two other French clusters : Alsace Bio-Valley and Cancer-Bio-Santé. This cooperation has resulted in the creation of Lifescience Corridor France (LCF) in December 2007.
More information
The events of international linkages
In recent years, Lyonbiopole managed to strengthen its presence abroad, notably by organizing business networking events of international scope:
> The “ French American Biotech Symposium”, FABS
> The “Fast-Track R&D Partnering with France” FTRD
> The “French American Scientific Track”, FAST
More information
They speak about...
« I attach great importance to our relations with China, particularly with Shanghai, which I know since 1987. I am very pleased to sign the extension of our partnership between Fudan University Cancer Hospital and Mérieux Institute. In this laboratory, Transgene and bioMérieux collaborate closely with oncologists of this great hospital. On the other hand, acquisitions of Meikang Biotech and Zenka now allows us to produce in Shanghai rapid tests and culture media essential to the diagnosis of infectious diseases. »
Alain Mérieux
bioMérieux - President